Basic Information
ID: ALA3994798
Type: Functional
Description: Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA infected in HEL cells assessed as reduction in virus plaque formation
Format: BAO_0000219
Organism: Human alphaherpesvirus 3
Strain: strain Oka vaccine
Target: Human alphaherpesvirus 3(ALA613132)
Document: ALA3994569
Antiviral activity against thymidine kinase expressing Varicella-Zoster virus OKA infected in HEL cells assessed as reduction in virus plaque formation: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA3994798
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 333.14 | -0.46 | -0.46 |
| 225.21 | -1.33 | -1.33 |
| 487.49 | 3.44 | 3.44 |
| 581.58 | 5.15 | 5.15 |
| 501.48 | 3.08 | 3.08 |
| 577.57 | 4.65 | 4.65 |
| 505.48 | 3.58 | 3.58 |
| 581.58 | 5.15 | 5.15 |
| 595.56 | 4.79 | 4.79 |
| 519.47 | 3.22 | 3.22 |
| 451.42 | 1.93 | 1.93 |
| 595.56 | 4.79 | 4.79 |
| 505.48 | 3.58 | 3.58 |
| 501.48 | 3.08 | 3.08 |
| 505.48 | 3.58 | 3.58 |
| 581.58 | 5.15 | 5.15 |
| 595.56 | 4.79 | 4.79 |
| 595.56 | 4.79 | 4.79 |
| 563.59 | 5.01 | 5.01 |
| 505.48 | 3.58 | 3.58 |
| 505.48 | 3.58 | 3.58 |
| 451.42 | 1.93 | 1.93 |
| 581.58 | 5.15 | 5.15 |
| 519.47 | 3.22 | 3.22 |
| 519.47 | 3.22 | 3.22 |
| 519.47 | 3.22 | 3.22 |
| 519.47 | 3.22 | 3.22 |
| 519.47 | 3.22 | 3.22 |
| 487.49 | 3.44 | 3.44 |
| 595.56 | 4.79 | 4.79 |
| 577.57 | 4.65 | 4.65 |
| 505.48 | 3.58 | 3.58 |